Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus

Nature Structural and Molecular Biology

Volumn 12, Issue 1, 2005, Pages 60-66

  De Parseval, Aymeric ^a   Chatterji, Udayan ^a   Morris, Garrett ^a   Sun, Peiqing ^a   Olson, Arthur J ^a   Elder, John H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; GENE CONSTRUCT; GENE INTERACTION; GENE MAPPING; MOLECULAR MODEL; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ASPARTIC ACID; BINDING SITES; CATS; CHO CELLS; CRICETINAE; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CXCR4; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 11444269806     PISSN: 15459993     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsmb872     Document Type: Article

References (50)

1. Pedersen, N.C., Ho, E.W., Brown, M.L. & Yamamoto, J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235, 790-793 (1987).
2. Willett, B.J. et al. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71, 6407-6415 (1997).
3. de Parseval, A. & Elder, J.H. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J. Virol. 75, 4528-4539 (2001).
4. de Parseval, A., Su, S.V., Elder, J.H. & Lee, B. Specific interaction of feline immunodeficiency virus surface glycoprotein with human DC-SIGN. J. Virol. 78, 2597-2600 (2004).
5. de Parseval, A., Ngo, S. & Elder, J.H. Factors that increase effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication. J. Virol. 78, 9132-9143 (2004).
6. Dalgleish, A.G. et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767 (1984).
7. Klatzmann, D. et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768 (1984).
8. Saphire, A.C., Bobardt, M.D., Zhang, Z., David, G. & Gallay, P.A. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol. 75, 9187-9200 (2001).
9. Geijtenbeek, T.B. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587-597 (2000).
10. Norimine, J. et al. Feline CD4 molecules expressed on feline non-lymphoid cell lines are not enough for productive infection of highly lymphotropic feline immunodeficiency virus isolates. Arch. Virol. 130, 171-178 (1993).
11. de Parseval, A., Chatterji, U., Sun, P. & Elder, J.H. Feline immunodeficiency virus targets activated CD4+T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. USA 101, 13044-13049 (2004).
12. Shimojima, M. et al. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303, 1192-1195 (2004).
13. Sattentau, Q.J. & Moore, J.P. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174, 407-415 (1991).
14. Sattentau, Q.J., Moore, J.P., Vignaux, F., Traincard, F. & Poignard, P. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67, 7383-7393 (1993).
15. Schenten, D. et al. Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells. J. Virol. 73, 5373-5380 (1999).
16. Sullivan, N. et al. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 72, 4694-4703 (1998).
17. Latza, U. et al. The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur. J. Immunol. 24, 677-683 (1994).
18. Kwon, B.S. & Weissman, S.M. cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. USA 86, 1963-1967 (1989).
19. Itoh, N. et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243 (1991).
20. Loetscher, H, et al. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61, 351-359 (1990).
21. Durkop, H. et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68, 421-427 (1992).
22. Camerini, D., Walz, G., Loenen, W.A., Borst, J. & Seed, B. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol. 147, 3165-3169 (1991).
23. Schall, T.J. et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61, 361-370 (1990).
24. Smith, C.A. et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248, 1019-1023 (1990).
25. Stamenkovic, I., Clark, E.A. & Seed, B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8, 1403-1410 (1989).
26. Johnston, J.C. et al. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 73, 4991-5000 (1999).
27. Banner, D.W. et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF β complex: implications for TNF receptor activation. Cell 73, 431-445 (1993).
28. Arthos, J. et al. Identification of the residues in human CD4 critical for the binding of HIV. Cell 57, 469-481 (1989).
29. Landau, N.R., Warton, M. & Littman, D.R. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature 334, 159-162 (1988).
30. Sattentau, Q.J. et al. Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J. Exp. Med. 170, 1319-1334 (1989).
31. Peterson, A. & Seed, B. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 54, 65-72 (1988).
32. Clayton, L.K. et al. Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding. Nature 335, 363-366 (1988).
33. Mizukami, T., Fuerst, T.R., Berger, E.A. & Moss, B. Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis. Proc. Natl. Acad. Sci. USA 85, 9273-9277 (1988).
34. Schockmel, G.A., Somoza, C., Davis, S.J., Williams, A.F. & Healey, D. Construction of a binding site for human immunodeficiency virus type 1 gp120 in rat CD4. J. Exp. Med. 175, 301-304 (1992).
35. Wang, J.H. et al. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348, 411-418 (1990).
36. Ryu, S.E. et al. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 348, 419-426 (1990).
37. Naismith, J.H., Devine, T.Q., Brandhuber, B.J. & Sprang, S.R. Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J. Biol. Chem. 270, 13303-13307 (1995).
38. Naismith, J.H., Devine, T.Q., Kohno, T. & Sprang, S.R. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure 4, 1251-1262 (1996).
39. Al-Shamkhani, A., Mallett, S., Brown, M.H., James, W. & Barclay, A.N. Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells. J. Biol. Chem. 272, 5275-5282 (1997).
40. Arch, R.H. & Thompson, C.B. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol. Cell. Biol. 18, 558-565 (1998).
41. Kawamata, S., Hori, T., Imura, A., Takaori-Kondo, A. & Uchiyama, T. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-κB activation. J. Biol. Chem. 273, 5808-5814 (1998).
42. Prell, R.A. et al. OX40-mediated memory T cell generation is TNF receptor-associated factor 2 dependent. J. Immunol. 171, 5997-6005 (2003).
43. Chan, D.C., Fass, D., Berger, J.M. & Kim, P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273 (1997).
44. Weissenhorn, W., Dessen, A., Harrison, S.C., Skehel, J.J. & Wiley, D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426-430 (1997).
45. Trkola, A. et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384, 184-187 (1996).
46. Wu, L. et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384, 179-183 (1996).
47. Ali, S.A. & Steinkasserer, A. PCR-ligation-PCR mutagenesis: a protocol for creating gene fusions and mutations. Biotechniques 18, 746-750 (1995).
48. Phillips, T.R. et al. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 64, 4605-4613 (1990).
49. DeClercq, E. et al. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob. Agents Chemother. 38, 668-674 (1994).
50. Engelman, D.M., Steitz, T.A. & Goldman, A. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Annu. Rev. Biophys. Chem. 15, 321-353 (1986).